Shr profit seven ct v n/a Net profit 587,000 v profit 3,231,000 Sales 18.5 mln v 18.7 mln Nine Mths Shr loss 39 ct v n/a Net loss 2,368,000 v protit 7,165,000 Sales 55.4 mln v 54.2 mln Note : Current nine month figure include extraordinary loss 1.2 mln dlrs , 17 ct per share , resulting cost associated restructuring .
Prior quarter nine month per share figure applicable company began operation October , 1986 acquisition Gould Inc 's & lt ; GLD > medical product group .
Reuter & # 3 ; 